Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
E-pub ahead of print

An overview of current and emerging devices for percutaneous left atrial appendage closure

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. β-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Glucagon-like peptide 1--a cardiologic dimension

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Therapeutic potential of functional selectivity in the treatment of heart failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Mortality and morbidity of major congenital heart disease related to general prenatal screening for malformations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Copenhagen Baby Heart Study: a population study of newborns with prenatal inclusion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Incidence of infective endocarditis in patients considered at moderate risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Danny H F Chow
  • Yam-Hong Wong
  • Jai-Wun Park
  • Yat-Yin Lam
  • Tom De Potter
  • Josep Rodés-Cabau
  • Lluis Asmarats
  • Marcus Sandri
  • Eleftherios Sideris
  • Trevor McCaw
  • Randall J Lee
  • Horst Sievert
  • Lars Søndergaard
  • Ole De Backer
Vis graf over relationer

Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.

OriginalsprogEngelsk
TidsskriftTrends in Cardiovascular Medicine
ISSN1050-1738
DOI
StatusE-pub ahead of print - 2019

ID: 56524064